RGC

Regencell Bioscience Holdings Limited NASDAQ Listed Jul 16, 2021

Healthcare ·Drug Manufacturers - Specialty & Generic ·HK · regencellbioscience.com

$11.27

+7.23% vs $10.51

Mkt Cap $5.6B

52w Low $9.39 3.2% of range 52w High $69.00

50d MA $25.26 200d MA $22.43

P/E (TTM) —

EV/EBITDA —

P/B 1150.0x

Debt/Equity 0.1x

ROE -73.8%

P/FCF -1591.1x

RSI (14) 11.90

ATR (14) $2.38

Beta 2.25

50d MA $25.26

200d MA $22.43

Avg Volume 126.4K

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

SIC Code

2833

CIK (SEC)

1829667

Phone

852 2155 0823

First Commercial Building · Causeway Bay KY1-1107 · HK

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Jun 15, 2026	AMC	—	-0.01	—	17.09	-0.7%	-2.1%	-11.4%	-19.0%	-12.5%	—	—
Jun 11, 2026	AMC	—	-0.01	—	19.69	+0.1%	-4.4%	-9.2%	-2.1%	-11.4%	-19.0%	—
Jun 10, 2026	AMC	—	-0.01	—	20.45	+0.2%	-3.7%	-4.4%	-9.2%	-2.1%	-11.4%	—
Jun 9, 2026	AMC	—	-0.01	—	20.31	-1.5%	+0.7%	-3.7%	-4.4%	-9.2%	-2.1%	—
Jun 8, 2026	AMC	—	-0.01	—	21.39	-0.2%	-5.0%	+0.7%	-3.7%	-4.4%	-9.2%	—
Jun 5, 2026	AMC	—	-0.01	—	19.99	+6.2%	+7.0%	-5.0%	+0.7%	-3.7%	-4.4%	—
Jun 2, 2026	AMC	—	-0.01	—	23.15	+1.3%	+2.6%	-6.7%	-9.8%	+7.0%	-5.0%	—
Nov 18, 2025	AMC	—	-0.00	—	13.09	-0.9%	-1.7%	-1.9%	-1.1%	-6.4%	-3.4%	—
Jun 26, 2025	AMC	—	-0.14	—	20.19	-1.9%	-13.8%	-2.1%	-14.3%	-29.0%	+121.9%	—
Jan 26, 2024	AMC	—	0.00	—	0.22	-0.6%	-0.6%	-0.6%	-2.3%	-0.1%	+0.0%	—
Oct 27, 2023	AMC	—	-0.01	—	0.43	-1.8%	-3.9%	+1.7%	-11.9%	+0.6%	-0.6%	—
Jan 30, 2023	AMC	—	-0.01	—	0.75	+1.4%	+1.4%	+3.8%	-0.9%	+0.0%	+0.0%	—
Dec 30, 2021	AMC	—	-0.01	—	0.79	-0.0%	+6.1%	-3.9%	+12.3%	-7.0%	+9.4%	—
Dec 30, 2020	AMC	—	0.00	—	—	—	—	—	—	—	—	—
Jun 30, 2020	AMC	—	0.00	—	—	—	—	—	—	—	—	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 2	B. Riley	Downgrade	Buy → Neutral	—	—	—	—	—	—	—	—	—
Dec 6	Macquarie	Downgrade	Outperform → Neutral	—	—	—	—	—	—	—	—	—
Dec 6	Moffett Nathanson	Upgrade	Sell → Neutral	—	—	—	—	—	—	—	—	—
Dec 6	RBC Capital	Downgrade	Outperform → Perform	—	—	—	—	—	—	—	—	—

Institutional (13F) — Top 19 All ↗

#	Manager	Shares	Value	Chg	Period
1	Morgan Stanley	42,848	$900K	Reduced	Dec 2025
2	Marex Group Plc	31,600	$804K	New	Mar 2026
3	Ubs Group Ag	23,885	$607K	Added	Mar 2026
4	Bank Of America Corp /de/	17,172	$437K	Added	Mar 2026
5	Hudson Bay Capital Management Lp	13,107	$275K	New	Dec 2025
6	Amundi	8,595	$219K	New	Mar 2026
7	Federation Des Caisses Desjardins Du Quebec	2,231	$57K	New	Mar 2026
8	Eversource Wealth Advisors, Llc	1,370	$42K	Added	Mar 2026
9	Jpmorgan Chase & Co	845	$20K	New	Mar 2026
10	Russell Investments Group, Ltd.	760	$19K	New	Mar 2026
11	Farther Finance Advisors, Llc	201	$7K	Reduced	Mar 2026
12	Northwestern Mutual Wealth Management Co	301	$6K	New	Dec 2025
13	Blue Trust, Inc.	216	$5K	New	Dec 2025
14	Royal Bank Of Canada	69	$2K	New	Mar 2026
15	Bell Investment Advisors, Inc	20	$509	New	Mar 2026
16	Rockefeller Capital Management L.p.	20	$509	Reduced	Mar 2026
17	Cornerstone Financial Management Llc	15	$381	New	Mar 2026
18	Bare Financial Services, Inc	14	$356	New	Mar 2026
19	Gamma Investing Llc	8	$203	New	Mar 2026

Mutual Funds / ETFs (N-PORT) — Top 1 All ↗

#	Fund	Shares	Value	Period
1	Goldman Sachs MarketBeta International Equity ETF	1,290	$34K	Feb 2026

Data updated apr 26, 2026 10:38pm · Source: financialmodelingprep.com